These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4882442)

  • 1. Haemodynamic action of thymoxamine (an alpha-adrenergic blocking agent) in occlusive peripheral arterial disease.
    Myers KA; Hobbs JT; Irvine WT
    Cardiovasc Res; 1968 Oct; 2(4):360-6. PubMed ID: 4882442
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of a new alpha-blocking vasodilator agent (thymoxamine) in peripheral vascular disease.
    Kane SP
    Br J Surg; 1970 Dec; 57(12):921-6. PubMed ID: 4395088
    [No Abstract]   [Full Text] [Related]  

  • 3. Vasodilator drugs in the treatment of peripheral arterial insufficiency.
    Hansteen V; Lorentsen E
    Acta Med Scand Suppl; 1974; 556():3-62. PubMed ID: 4366049
    [No Abstract]   [Full Text] [Related]  

  • 4. The significance of vasodilator therapy in obliterative arterial disease.
    Thulesius O
    Scand J Clin Lab Invest Suppl; 1967; 99():222-4. PubMed ID: 6056925
    [No Abstract]   [Full Text] [Related]  

  • 5. [Muscular blood flow in occlusive diseases of arteries of the lower limbs and the effect of medicinal preparations].
    Lyskova MN; Kuz'min VP; Tsypliaev VA; Bogoliubov VM
    Klin Med (Mosk); 1975 Apr; 53(4):47-50. PubMed ID: 1152370
    [No Abstract]   [Full Text] [Related]  

  • 6. Testosterone in the treatment of arterial insufficiency of the lower limbs.
    Hentzer E; Madsen PC
    Scand J Clin Lab Invest Suppl; 1967; 99():198-206. PubMed ID: 4862833
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiovascular effects of intravenous indoramin hydrochloride in man.
    Coleman AJ; Leary WP; Asmal AC
    J Int Med Res; 1979; 7(6):511-8. PubMed ID: 520654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of vasodilators in peripheral arterial insufficiency].
    Hansteen V; Lorentsen E
    Tidsskr Nor Laegeforen; 1971 Aug; 91(24):1731-4. PubMed ID: 5111131
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of vasodilator drugs on skin blood-flow in peripheral vascular occlusion. A double-blind trial using tolazoline.
    Thomas M; Campbell H; Heard G
    Br J Surg; 1968 Aug; 55(8):588-90. PubMed ID: 4874477
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation of delayed-action Tebonin with the study of muscle flow, using xenon 133].
    Matteoni R; Reale R; Lauri D; Sirolli C; Tata MV
    Minerva Cardioangiol; 1973 Apr; 21(4):264-71. PubMed ID: 4710123
    [No Abstract]   [Full Text] [Related]  

  • 11. [Continuous intra-arterial infusions in obliterating diseases of the lower limbs].
    Chudakov MI; Vorotyntsev SF
    Khirurgiia (Mosk); 1974 May; (5):87-90. PubMed ID: 4457694
    [No Abstract]   [Full Text] [Related]  

  • 12. Regression of peripheral atherosclerosis during therapy with high doses of nicotinic acid.
    Ost CR; Sténson S
    Scand J Clin Lab Invest Suppl; 1967; 99():241-5. PubMed ID: 6056927
    [No Abstract]   [Full Text] [Related]  

  • 13. [Dalargin in the treatment of arteriosclerosis obliterans of the lower extremities].
    Dudko VA; Fedorova NA; Didenko VA; Zoloev GK
    Sov Med; 1990; (2):90-2. PubMed ID: 2192476
    [No Abstract]   [Full Text] [Related]  

  • 14. [The vasoactivogram in the treatment of peripheral arteriopathies].
    Romeo S; Spinella G; Sciacchitanto D
    Angiologia; 1975; 27(1):7-25. PubMed ID: 1111377
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemodynamic effect of cilostazol on increasing peripheral blood flow in arteriosclerosis obliterans.
    Yasuda K; Sakuma M; Tanabe T
    Arzneimittelforschung; 1985; 35(7A):1198-200. PubMed ID: 4074434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vasodilator activity of cetiedil in patients with peripheral arterial insufficiency and vasospastic changes: hemodynamic study].
    Matesanz JM; Reina T; García F; Acin F; Méndez B; Tamames S
    Med Clin (Barc); 1982 Sep 1-15; 79(4):173-6. PubMed ID: 7144291
    [No Abstract]   [Full Text] [Related]  

  • 17. [Test of active vasodilatation in the evaluation of peripheral regional circulation in sclerotic and diabetic arteriopathies].
    Dughera L; Macchioni P; Di Leo M; Nosenzo C
    Minerva Cardioangiol; 1972 Sep; 20(9):484-96. PubMed ID: 5071470
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of vasodilator drugs in the treatment of diabetic arteriosclerosis obliterans.
    MOSS JM
    J Am Geriatr Soc; 1954 May; 2(5):284-7. PubMed ID: 13162729
    [No Abstract]   [Full Text] [Related]  

  • 19. [Usefulness of vasodilator agents Cavinton and Halidor in circulatory insufficiency of the lower limbs].
    Jonderko G; Szramek-Urbaniak A; Bednarczyk-Kałuzna M
    Przegl Lek; 1982; 39(9):617-20. PubMed ID: 7178532
    [No Abstract]   [Full Text] [Related]  

  • 20. [Alpha blocking properties of dihydro ergot derivatives. Findings on skin and muscle temperature].
    D'Ayala Valva G; Dabizzi RP; Banchelli A
    Riv Crit Clin Med; 1967 Aug; 67(3):191-9. PubMed ID: 4395433
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.